Study title: Saunders P.R, Smith F, Schusky R.W.: Echinacea purpurea in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections. Can J Physiol Pharmacol. 2007 Nov; 85(11): 1195-1199
Type of medicine: Herbal and homoeopathic medicines | |||||
Therapeutic area: Respiratory Tract Diseases [C08] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: Dried, pressed plant sap of Echinacea purpurea 176 mg/tablet, corresponding to 4 g herbal drug/tablet | |||||
ATC code: R02 | |||||
Document link: | |||||
Document date: | |||||
Study number: PMID 18066121 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |